Drugs / Celgosivir

Trials 8

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT00002329 — HIV infectious disease Hoechst Marion Roussel Completed No outcome recorded
Phase 1/21 trial · 1 missed
Phase 1/2 NCT01619969 Jul 2012 → Mar 2013 dengue disease Singapore General Hospital Completed Missed primary
Phase 26 trials
Phase 2 NCT00332176 Jun 2006 → Dec 2008 chronic hepatitis C virus infection BioWest Therapeutics Inc Unknown No outcome recorded
Phase 2 NCT00292084 Feb 2006 → Oct 2007 chronic hepatitis C virus infection BioWest Therapeutics Inc Completed No outcome recorded
Phase 2 NCT00217139 Sep 2005 → Sep 2006 chronic hepatitis C virus infection BioWest Therapeutics Inc Completed No outcome recorded
Phase 2 NCT00157534 Oct 2004 → Aug 2005 chronic hepatitis C virus infection BioWest Therapeutics Inc Completed No outcome recorded
Phase 2 NCT00002151 — HIV infectious disease Hoechst Marion Roussel Completed No outcome recorded
Phase 2 NCT00002150 — HIV infectious disease Hoechst Marion Roussel Completed No outcome recorded
Comparator or background therapy1 trial
Phase 1/2 NCT02569827 Comparator Dec 2018 → Aug 2019 dengue disease Singapore General Hospital Withdrawn No outcome recorded Stop: Business

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 11 sources stand behind the page.

FieldValueCited text
Known as Celgosivir ClinicalTrials.gov intervention name — accepted as the source's own label NCT00157534 ↗
8

NCT00217139 ↗

NCT00002150 ↗

NCT00332176 ↗

NCT00292084 ↗

NCT02569827 ↗

NCT00002329 ↗

NCT01619969 ↗

NCT00002151 ↗

Known as Celgosivir hcl ChEMBL registry synonym — accepted as the source's own label CHEMBL2110737 ↗
Known as CELGOSIVIR HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL2110737 ↗
Known as MDL 28,574A ChEMBL registry synonym — accepted as the source's own label CHEMBL2110737 ↗
Action Inhibit “We tested the α-glucosidase inhibitor celgosivir as a treatment for acute dengue fever.” PMID 24877997 ↗ May 2014
Modality Small molecule — CHEMBL2110737 ↗
Route Oral “administered as oral solution” NCT00002329 ↗